Skip to search.
 FTSE 100 Down 2.27%
Streaming
Ticker Tape: On

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM

10.93 Down 0.05(0.46%) 15:32 - Nasdaq Real Time Price

Add to Portfolio
Prev Close:10.98
Open:10.75
Bid:10.72 x 100
Ask:10.79 x 200
1y Target Est:8.50
Beta:1.81
Next Earnings Date:29-Jul-13OSIR Earnings announcement
Day's Range:10.37 - 10.98
52wk Range:5.72 - 14.46
Volume:17,427
Avg Vol (3m):141,608
Market Cap:359.94m
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for OSIR at this time.

Comparison

Symbol% ChgMkt Cap
OSIRDown 0.46%359.94m
RHHBYN.MXUp 0.14%2.66t
SHP.LDown 1.30%11.73b
SUNPHARMA.NSUp 0.41%1.04t
GILD.MXDown 1.48%1.04t

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.31
Quarterly EPS Est (Jun-13) :-0.09
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing of therapeutic products to treat medical conditions in the inflammatory, cardiovascular, orthopedic, and wound healing markets. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback